Skip to main content

IPHA · Innate Pharma SA · Proposed Sales

Track IPHA — free
$1.63 +0.03 (+1.88%) At close · Sep 30
Market Cap
$189.89M
Shares
111.70M
Volume · Sep 30 37.81K Avg daily vol (3M) 150.69K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 1 filings 1 filers Visit website Investor relations